CytoMed Therapeutics (GDTC) Prepaid Assets (2021 - 2023)

CytoMed Therapeutics (GDTC) has disclosed Prepaid Assets for 3 consecutive years, with $117774.5 as the latest value for Q4 2023.

  • Quarterly Prepaid Assets rose 261.91% to $117774.5 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $117774.5 through Dec 2023, up 261.91% year-over-year, with the annual reading at $118429.9 for FY2023, 261.38% up from the prior year.
  • Prepaid Assets hit $117774.5 in Q4 2023 for CytoMed Therapeutics, up from $32542.7 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $117774.5 in Q4 2023 to a low of $32542.7 in Q4 2022.
  • Historically, Prepaid Assets has averaged $84006.1 across 3 years, with a median of $101701.0 in 2021.
  • Biggest five-year swings in Prepaid Assets: crashed 68.0% in 2022 and later skyrocketed 261.91% in 2023.
  • Year by year, Prepaid Assets stood at $101701.0 in 2021, then plummeted by 68.0% to $32542.7 in 2022, then surged by 261.91% to $117774.5 in 2023.
  • Business Quant data shows Prepaid Assets for GDTC at $117774.5 in Q4 2023, $32542.7 in Q4 2022, and $101701.0 in Q4 2021.